Many are the visionaries of the future who for many years have seen in 3D printing a new technology not only capable of revolutionizing the industry as we know it, but also having the power to change practically the whole world. One of the fields where all its possibilities are being investigated the most is that of medicine where, even they have already been achieved implant blood vessels in animals.
This milestone has been achieved by Kang yujian, scientist and CEO of the Chinese biotech company Revotek, which would have been responsible for the manufacture of the blood vessel and the subsequent transplantation in rhesus monkeys. As has been publicly commented through a press release, it appears that the blood vessels would have managed to regenerate in just seven days.
Revotek succeeds in developing a blood vessel that has subsequently been implanted in several monkeys.
Going into a little more detail, we learn that this has been possible thanks to the use of a 3D bio-printer exclusively developed by Revotek. This makes use of stem cells through which a blood vessel can be created, as is the case, to later be implanted in the abdominal aorta of monkeys. Apparently, both the biological functionality and the structure of this architecture is the same as that of the real ones.
As Kang Yujian has commented, it seems that Revotek today has successfully transplanted printed blood vessels into 30 rhesus monkeys. getting 100% of the specimens to survive the operation and could get on with their lives. It is expected that, thanks to this technology, some 1.800 billion relatives with cardiovascular diseases in the world can benefit.